These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 18645347

  • 1. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
    Bermúdez V, Cano R, Cano C, Bermúdez F, Leal E, Acosta K, Mengual E, Arraiz N, Briceño C, Gómez J, Bustamante M, Aparicio D, Cabrera M, Valdelamar L, Rodriguez M, Manuel V, Hernández R.
    Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347
    [Abstract] [Full Text] [Related]

  • 2. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [Abstract] [Full Text] [Related]

  • 3. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
    Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Piccinni MN, Fogari E, Salvadeo S, Ciccarelli L, Fogari R.
    Diabetes Res Clin Pract; 2005 Jul; 69(1):5-13. PubMed ID: 15955382
    [Abstract] [Full Text] [Related]

  • 5. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [Abstract] [Full Text] [Related]

  • 6. Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study.
    Pfützner A, Derwahl M, Jacob S, Hohberg C, Blümner E, Lehmann U, Fuchs W, Forst T.
    Diabetes Technol Ther; 2010 Aug; 12(8):599-604. PubMed ID: 20615100
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of rosiglitazone and metformin in Greek patients with recently diagnosed type 2 diabetes.
    Iliadis F, Kadoglou NP, Hatzitolios A, Karamouzis M, Alevizos M, Karamitsos D.
    In Vivo; 2007 Aug; 21(6):1107-14. PubMed ID: 18210765
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
    Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.
    Intern Med J; 2007 Feb; 37(2):79-86. PubMed ID: 17229249
    [Abstract] [Full Text] [Related]

  • 9. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [Abstract] [Full Text] [Related]

  • 10. Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.
    Forst T, Lübben G, Hohberg C, Kann P, Sachara C, Gottschall V, Friedrich C, Rosskopf R, Pfützner A.
    Microcirculation; 2005 Jun; 12(7):543-50. PubMed ID: 16207627
    [Abstract] [Full Text] [Related]

  • 11. [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus].
    Tang JZ, Mao JP, Yang ZF, Zhou ZG, Tang WL, Feng Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):631-4. PubMed ID: 16114544
    [Abstract] [Full Text] [Related]

  • 12. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ, Goldenberg N, Sieve L, Wang P.
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [Abstract] [Full Text] [Related]

  • 13. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.
    Gao H, Xiao W, Wang C, Zhang J, Yang Y, Yang J, Yang W, Hong T.
    Int J Clin Pract; 2008 May; 62(5):695-700. PubMed ID: 18412932
    [Abstract] [Full Text] [Related]

  • 14. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
    Mu PW, Chen YM, Lu HY, Wen XQ, Zhang YH, Xie RY, Shu J, Wang MM, Zeng LY.
    Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
    [Abstract] [Full Text] [Related]

  • 15. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 16. beta-cell function and anti-diabetic pharmacotherapy.
    Del Prato S, Bianchi C, Marchetti P.
    Diabetes Metab Res Rev; 2007 Oct; 23(7):518-27. PubMed ID: 17883249
    [Abstract] [Full Text] [Related]

  • 17. Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats.
    Sharma AK, Srinivasan BP.
    Eur J Pharm Sci; 2009 Dec 08; 38(5):433-44. PubMed ID: 19765654
    [Abstract] [Full Text] [Related]

  • 18. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
    Xu L, Man CD, Charbonnel B, Meninger G, Davies MJ, Williams-Herman D, Cobelli C, Stein PP.
    Diabetes Obes Metab; 2008 Dec 08; 10(12):1212-20. PubMed ID: 18476982
    [Abstract] [Full Text] [Related]

  • 19. Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study.
    Shargorodsky M, Michaelova K, Boaz M, Gavish D, Zimlichman R.
    Diabet Med; 2007 Nov 08; 24(11):1254-60. PubMed ID: 17725634
    [Abstract] [Full Text] [Related]

  • 20. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug 08; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.